CAH Cardinal Health, Inc. Loading...

From COR earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
12:30
Aug 05 ◎
Eva Boratto CFO, Cencora, Inc. COR Q3 FY26 call
After lapping customer losses, the US segment expects its strongest organic growth of the year in the fiscal fourth quarter, implying a significant decoupling from broader macro trends. — This suggests market share gains or durable tailwinds in the US specialty distribution market.
CAH
MED
13:30
Feb 04 ◎
Jim Cleary CFO, Cencora, Inc. COR Q1 FY26 call
Cencora's US operating income growth of 21% in Q1 was aided by the 'loss of an oncology customer' to a competitor, implying a competitor (likely McKesson or Cardinal Health) gained a major oncology distribution contract. — Indicates a competitive share shift in oncology distribution, where a large customer was acquired by a competitor.
CAH
MED

About CAH Analyst Coverage

Buzzberg tracks CAH (Cardinal Health, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Eva Boratto, Jim Cleary.